Two donor kidneys transported from Hawaii to the East Coast have demonstrated how portable perfusion technology could expand the geographic reach of the U.S. transplant system.
The kidneys, recovered from the same donor at The Queen’s Medical Center in Honolulu, were transported to separate recipients in New York City and Hartford, Connecticut. The journeys covered approximately 4,311 and 4,354 nautical miles, respectively, with the organs traveling in the cargo holds of commercial aircraft. The Connecticut case included a scheduled layover in Denver and reached a total ischemic time of 18 hours and 29 minutes—reportedly the longest documented donor-kidney transport to date.
Both kidneys were preserved using Paragonix Technologies’ KidneyVault Portable Renal Perfusion System. Unlike conventional static cold storage, the system provides continuous hypothermic machine perfusion while the organ is in transit. It also gives transplant teams real-time visibility into temperature and preservation conditions.
KidneyVault is designed to maintain kidneys between 4°C and 8°C for as long as 24 hours, although transplantability remains a clinical decision when preservation extends beyond commonly accepted timeframes.
The business significance
The commercial opportunity is larger than simply replacing the traditional organ cooler.
Broader organ-sharing policies have increased the distances transplant teams must travel to recover donor organs. That creates demand for preservation systems capable of supporting commercial flights, connecting itineraries, remote monitoring and longer allocation windows.
Paragonix, now part of Getinge, is increasingly positioning itself as an integrated transplant-infrastructure company rather than solely a medical-device manufacturer. Its offering combines organ-preservation hardware, digital tracking, procurement support, logistics coordination and clinical-outcomes registries. The company reports that its technologies have preserved more than 20,000 donor organs and supported more than 250 transplant centers globally.
For transplant centers and organ-procurement organizations, a portable system could increase the number of organs they are willing to accept from distant donors. For Paragonix, every additional journey creates potential demand for devices, consumables, logistics support and data services.
The Hawaii cases do not, by themselves, establish that KidneyVault improves long-term transplant outcomes. They do, however, provide an operational demonstration of something commercially important: advanced preservation can turn organs that were once considered geographically impractical into viable transplant opportunities.
The emerging organ-preservation market is therefore becoming a logistics and infrastructure market. The companies that successfully integrate biological preservation with transportation, monitoring and clinical evidence may become essential intermediaries in a more national—and eventually international—organ-sharing network.
Article from here link.
Leave a comment